To describe the 22nd case of Crouzan syndrome with acanthosis nigricans, a hyperkeratotic skin disorder with hyperpigmentation.
Methods
DNA analysis and sequencing of the FGFR3gene were performed.
Results
The 13-year-old Japanese boy described here also had dyspnea, facial palsy, sensorineural hearing loss, and skeletal and mental retardation. Examination of a skin biopsy specimen revealed the typical findings of acanthosis nigricans. Genetic analysis revealed the Ala391Glu mutation in one FGFR3 gene.
Conclusions
Crouzon syndrome with acanthosis nigricans is a distinct clinical entity different from classic Crouzon syndrome.
BellusG.A.GaudenzK.ZackaiE.H.ClarkeL.A.SzaboJ.FrancomanoC.A.MuenkeM.. Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes.Nat Genet.1996; 14: 174–176.
2.
BellusG.A.McIntoshI.SmithE.A.AylsworthA.S.KaitilaI.HortonW.A.GreenhawG.A.HechtJ.T.FrancomanoC.A.. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia.Nat Genet.1995; 10: 357–359.
3.
BreitbartA.S.EatonC.McCarthyJ.G.. Crouzon's syndrome associated with acanthosis nigricans: ramifications for the craniofacial surgeon.Ann Plast Surg.1989; 22: 310–315.
4.
CurthH.. The necessity of distinguishing four types of acanthosis nigricans. In: JadassohnW.SchirrenC., eds. XII Congressus Internationalis Dermatologiae Munich.Berlin: Springer-Verlag;1968: 557–558.
5.
GinesE.Rodriguez-PichardoA.JorqueraE.MorenoJ.C.CamachoF.. Crouzon disease with acanthosis nigricans and melanocytic nevi.Pediatr Dermatol.1996; 13: 18–21.
6.
GorlinR.J.. Fibroblast growth factors, their receptors and receptor disorders.J Craniomaxillofac Surg.1997; 25: 69–79.
7.
GriffithsW.LeighI.MarksR.. Disorders of keratinization. In: ChampionR.BurtonJ.EblingF., eds. Textbook of Dermatology.Oxford: Blackwell;1992: 1325–1390.
8.
IshigakiM.WadaC.Toyo-okaY.YamabeH.OhnukiY.TakadaF.YamazakiY.OhtaniH.. Frequent missense mutations of fibroblast growth factor receptor (FGFR) gene families in craniofacial syndromes in Japanese patients.Jpn J Clin Pathol.1996; 44: 439–443. In Japanese.
9.
KoizumiH.TomoyoriT.SatoK.C.OhkawaraA.. An association of acanthosis nigricans and Crouzon syndrome.J Dermatol.1992; 19: 122–126.
10.
MaizeJ.MetcalfJ.. Metabolic diseases of the skin. In: ElderD.ElenitsasR.JaworskyC.JohnsonCJr, eds. Lever's Histopathology of the Skin.Philadelphia: Lippincott-Raven;1997: 369–402.
MatsumotoK.UranoY.KuboY.NakanishiH.AraseS.. Mutations of the fibroblast growth factor receptor 2 gene in Japanese patients with Apert syndrome.Plast Reconstr Surg.1998; 101: 307–311.
13.
MeyersG.A.OrlowS.J.MunroI.R.PrzylepaK.A.JabsE.W.. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.Nat Genet.1995; 11: 462–464.
14.
MoloneyD.M.SlaneyS.F.OldridgeM.WallS.A.SahlinP.StenmanG.WilkieA.O.M.. Exclusive patternal origin of new mutations in Apert syndrome.Nat Genet.1996; 13: 48–53.
15.
MuenkeM.GrippK.W.McDonald-McGinnD.M.GaudenzK.WhitakerL.A.BartlettS.P.MarkowitzR.I.RobinN.H.NwokoroN.MulvihillJ.J.LoskenH.W.MullikenJ.B.GuttmacherA.E.WilroyR.S.ClarkeL.A.HollwayG.AdesL.C.HaanE.A.MulleyJ.C.CohenMMJrBellusG.A.FrancomanoC.A.MoloneyD.M.WallS.A.WilkieA.O.. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome.Am J Hum Genet.1997; 60: 555–564.
16.
MuenkeM.SchellU.HehrA.RobinN.H.LoskenH.W.SchinzelA.PulleynL.J.RutlandP.ReardonW.MalcolmS.WinterR.M.. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome.Nat Genet.1994; 8: 269–274.
17.
NagaseT.NagaseM.HiroseS.OhmoriK.. Japanese sisters with Pfeiffer syndrome and achondroplasia: a mutation analysis.J Craniofac Surg.1998a; 9: 477–480.
18.
NagaseT.NagaseM.HiroseS.OhmoriK.. Mutations in fibroblast growth factor receptor 2 gene and craniosynostosis syndromes in Japanese children.J Craniofac Surg.1998b; 9: 162–170.
19.
OrlowS.J.. Cutaneous findings in craniofacial malformation syndromes.Arch Dermatol.1992; 128: 1379–1386.
20.
Orr-UrtregerA.GivolD.YayonA.YardenY.LonaiP.. Developmental expression of two murine fibroblast growth factor receptors, flg and bek.Development.1991; 113: 1419–1434.
21.
PetersK.OrnitzD.WernerS.WilliamsL.. Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis.Dev Biol.1993; 155: 423–430.
22.
ReardonW.WinterR.M.RutlandP.PulleynL.J.JonesB.M.MalcolmS.. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome.Nat Genet.1994; 8: 98–103.
23.
ReddyB.S.GargB.R.PadiyarN.V.KrishnaramA.S.. An unusual association of acanthosis nigricans and Crouzon's disease—a case report.J Dermatol.1985; 12: 85–90.
24.
RischN.ReichE.W.WishnickM.M.McCarthyJ.G.. Spontaneous mutation and parental age in humans.Am J Hum Genet.1987; 41: 218–248.
25.
RousseauF.BonaventureJ.Legeal-MalletL.PeletA.RozetJ-MMaroteauxP.MerrerM.L.MunnichA.. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.Nature.1994; 371: 252–254.
26.
ShiangR.ThompsonL.M.ZhuY-ZChurchD.M.FielderT.J.BocianM.WinokurS.T.WasmuthJ.J.. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia.Cell.1994; 78: 335–342.
27.
Superti-FurgaA.EichG.BucherH.U.WisserJ.GiedionA.GitzelmannR.SteinmannB.. A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia.Eur J Pediatr.1995; 154: 215–219.
28.
Superti-FurgaA.LocherM.SteinlinM.EichG.HuismanT.SteinmannB.SailerH.BoltshauserE.. Crouzon syndrome with acanthosis nigricans, spinal stenosis and desmo-osteoblastomas: pleiotropic effects of the FGFR-3 ALA-391-GLU mutation.J Craniomaxillofac Surg.1996; 24(Suppl 1): 112.
29.
SuslakL.GlistaB.GertzmanG.B.LiebermanL.SchwartzR.A.DespositoF.. Crouzon syndrome with periapical cemental dysplasia and acanthosis nigricans: the pleiotropic effect of a single gene?Birth Defects1985; 21: 127–134.
30.
TavorminaP.L.ShiangR.ThompsonL.M.ZhuY-ZWilkinD.J.LachmanR.S.WilcoxW.R.RimoinD.L.CohnD.H.WasmuthJ.J.. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.Nat Genet.1995; 9: 321–328.
31.
WadaC.IshigakiM.Toyo-okaY.YamabeH.OhnukiY.TakadaF.YamazakiY.OhtaniH.. Nucleotide sequences at intron 6 and exon 7 junction of fibroblast growth factor receptor 2 and rapid mutational analysis in Apert syndrome.Jpn J Clin Pathol.1996; 44: 435–438. In Japanese.
32.
WilkesD.RutlandP.PulleynL.J.ReardonW.MossC.EllisJ.P.WinterR.M.MalcolmS.. A recurrent mutation, Ala391Glu, in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans.J Med Genet.1996; 33: 744–748.
